Paragon Care Limited (ASX:PGC) (“Paragon Care” or the “Company”) is pleased to report its financial results for the half year ended 31 December 2022 (“1H FY23”).
Key highlights from the results include:
-
Sales revenue up 38% to $153.9m
-
Underlying EBITDA* up 37% to $17.6m
-
Underlying NPAT* up 41% to $6.4m
-
0.6 cents per share fully franked interim dividend declared
For more information, download the attached PDF.
Download this document
